|
Programme
The meeting will take place over a three day period covering welcome address; Hugh Sinclair Lecture; 3 parallel sessions including - 10 plenary speakers; 1 invited keynote speaker; 45 invited symposium speakers; 34 abstract presenters; 6 Young Investigator presenters; and moderated poster sessions.
It is expected that the meeting, run jointly with the European Vascular Biology Organisation (EVBO) and British Atherosclerosis Society (BAS), will attract upwards of 400 participants including:
- Physicians and scientists
- Oncologists and cancer biologists
- Cardiologists and cardiovascular researchers
- Diabetologists and diabetes researchers
- Haematologists and thrombosis researchers
- Other areas e.g. ophthalmology, nephrology
- Cell and gene therapists
The meeting will be held at the University of Bristol.
All presentations will be held in the splendid Wills Memorial Building. Refreshments, buffet lunches, exhibition and poster displays will be located in the Merchant Venturers Building, less than a minutes walk from the meeting rooms so that no valuable networking time will be lost.
Download EMVBM 2007 Poster PDF - Adobe Acrobat Reader required
Update! Timings
Download 4th EMVBM programme summary PDF - Adobe Acrobat Reader required
Download 4th EMVBM workshop programme PDF - Adobe Acrobat Reader required
Download 4th EMVBM full programme PDF - Adobe Acrobat Reader required
Topics
Plenary sessions:
The Hugh Sinclair Lecture (G Hansson) Clinical Modulation of Angiogenesis (D Shima, N Ferrara, L Naldini) Vulnerable Plaque (R Virmani, M Daemen, J Nilsson) Phenotype of vascular cells (A Eichmann, L Claesson-Welsh, G Owens)
Workshops:
I - Atherosclerosis Track:
Vulnerable Plaque Imaging and Treatment (J Schaar, E Biessen, C Jackson) Genomics, Proteomics and Gene Therapy (M Mayr, A Horrevoets, S Yla-Hertuala) Immunology of Atherosclerosis (Z Mallat, F Mach, J-F Arnal) Leukocyte Interactions with the Vessel Wall (B Imhof, S Nourshaugh, D Greaves) Inflammation – Emerging Themes and Treatments (N Marx, A Tedgui, G Fitzgerald)
II - Endothelium and Angiogenesis Track:
Endothelial function (I Fleming, T Griffith, C Duplaa) Vascular Progenitors 1 (Q Xu, S Rafii, A Zeiher) Vascular Progenitors 2 (S Dimmeler, J Fog-Bentzon, D Losordo) Control of Vascular Permeability (V van Hinsbergh, D Bates, H Vink) Arterio-Venous-Lymphatic Differentiation (A Gitteberger, K Alitalo, H Augustin) Angiogenic Factors (C Emanueli, B Hemstead, E Keshet)
III - Cellular Dysfunction Track:
Diabetic Angiopathy (P Madeddu, K Channon, J Luc-Wautier) Oxidative Stress (B Berk, U Landmesser, J Jeremy) Neointima Formation (M Bond, N Morrell, G Pasterkamp) Apoptosis and Microparticles (M Bennett, B Binder, C Boulanger) Cell Cell Interactions (SJ George, B Kwak, E Dejena) Mechanical Factors and Vascular Remodelling (S Lehoux, G Garcia-Cardena, J de Mey)
|